The interaction between Semaglutide / Cyanocobalamin Injection and other antidiabetic medications requires careful consideration to avoid hypoglycemia while achieving optimal glycemic control
This review aims to consolidate available information from case reports and case series regarding rare skin-related adverse outcomes due to GLP-1 use, aiming to provide a comprehensive overview of the presentation, pathogenesis, and management for dermatologists and other clinicians
By stimulating endogenous growthhormone release, supporting melatonin production, and tempering nighttime cortisol spikes, these peptides deepen slowwave sleep, enhance recovery, and stabilize overall endocrine balance
Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus
Plaintiffs say that Novo Nordisk and other companies did not give enough warnings about these risks